Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma
2016
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
Histologic Considerations for Individualized Systemic Therapy Approaches for the Management of Non-small Cell Lung Cancer
2009
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases
2011
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy
2002
Lung cancer: current therapies and new targeted treatments
2016 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Invasive Aspergillosis in Transplant Recipients
1999
Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line
2014
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
2014
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Diabetic foot ulcers
2003 Standout
Treatment of Stage IV Non-small Cell Lung Cancer
2013
Granulocyte colony-stimulating factor primes NADPH oxidase in neutrophils through translocation of cytochrome b558 by gelatinase-granule release
2002 StandoutNobel
Host cell manipulation by the human pathogen Toxoplasma gondii
2008
Immunity to fungal infections
2011 Standout
Th1/Th2 in aspergillosis
2006
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Zygomycosis
2002
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Cytokines as therapy for opportunistic fungal infections
1998
In Vivo Treatment With Granulocyte Colony-Stimulating Factor Results in Divergent Effects on Neutrophil Functions Measured In Vitro
1998
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Zygomycetes in Human Disease
2000 Standout
In Vivo Treatment With Granulocyte Colony-Stimulating Factor Results in Divergent Effects on Neutrophil Functions Measured In Vitro
1998
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
2015
Leptomeningeal disease: current diagnostic and therapeutic strategies
2017
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Combined treatment: antifungal drugs with antibodies, cytokines or drugs
2000
Randomized Prospective Controlled Trial of Recombinant Granulocyte Colony-Stimulating Factor as Adjunctive Therapy for Limb-Threatening Diabetic Foot Infection
2001
Colony-stimulating factors and antibiotics—a new prospect in treating infectious diseases?
1998
Works of Jane E. Huang being referenced
BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer
2010
Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens
1997
Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases
2009
Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial
2011